Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Type 2 Diabetes Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Type 2 Diabetes Therapeuticsmarket, defines the market attractiveness level of Type 2 Diabetes Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Type 2 Diabetes Therapeutics industry, describes the types of Type 2 Diabetes Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Type 2 Diabetes Therapeutics market and the development prospects and opportunities of Type 2 Diabetes Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Type 2 Diabetes Therapeutics market in Chapter 13.
By Player:
Novo Nordisk
Astellas Pharma
Boehringer Ingelheim
Merck
Daiichi Sankyo
Novartis
Bristol-Myers Squibb
Sanofi
AstraZeneca
Eli Lilly
Biocon
By Type:
DPP-4 Inhibitors
Biguanides
Insulins
GLP-1 Receptor Agonists
Thiazolidenediones
Sulfonulureas
SGLT-2 Inhibitors
A-Glucosidase Inhibitors
Others
By End-User:
Hospital Pharmacy
Retail Pharmacies
Online Pharmacy
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Type 2 Diabetes Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Type 2 Diabetes Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Type 2 Diabetes Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Type 2 Diabetes Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Type 2 Diabetes Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Type 2 Diabetes Therapeutics Consumption (2017-2022)
-
7.2 United States Type 2 Diabetes Therapeutics Consumption (2017-2022)
-
7.3 Europe Type 2 Diabetes Therapeutics Consumption (2017-2022)
-
7.4 China Type 2 Diabetes Therapeutics Consumption (2017-2022)
-
7.5 Japan Type 2 Diabetes Therapeutics Consumption (2017-2022)
-
7.6 India Type 2 Diabetes Therapeutics Consumption (2017-2022)
-
7.7 South Korea Type 2 Diabetes Therapeutics Consumption (2017-2022)
8 Region and Country-wise Type 2 Diabetes Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Type 2 Diabetes Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Type 2 Diabetes Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Type 2 Diabetes Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Type 2 Diabetes Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Type 2 Diabetes Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Type 2 Diabetes Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Type 2 Diabetes Therapeutics Consumption Forecast (2022-2028)
9 Global Type 2 Diabetes Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Type 2 Diabetes Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global DPP-4 Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Biguanides Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Insulins Consumption and Growth Rate (2017-2022)
-
9.1.4 Global GLP-1 Receptor Agonists Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Thiazolidenediones Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Sulfonulureas Consumption and Growth Rate (2017-2022)
-
9.1.7 Global SGLT-2 Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.8 Global A-Glucosidase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Type 2 Diabetes Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Type 2 Diabetes Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Type 2 Diabetes Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global DPP-4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Biguanides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Insulins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global GLP-1 Receptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Thiazolidenediones Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Sulfonulureas Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global SGLT-2 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global A-Glucosidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.9 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Type 2 Diabetes Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Type 2 Diabetes Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Type 2 Diabetes Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Type 2 Diabetes Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Type 2 Diabetes Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Type 2 Diabetes Therapeutics Market Competitive Analysis
-
14.1 Novo Nordisk
-
14.1.1 Novo Nordisk Company Details
-
14.1.2 Novo Nordisk Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novo Nordisk Type 2 Diabetes Therapeutics Product and Service
-
14.2 Astellas Pharma
-
14.2.1 Astellas Pharma Company Details
-
14.2.2 Astellas Pharma Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Astellas Pharma Type 2 Diabetes Therapeutics Product and Service
-
14.3 Boehringer Ingelheim
-
14.3.1 Boehringer Ingelheim Company Details
-
14.3.2 Boehringer Ingelheim Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Boehringer Ingelheim Type 2 Diabetes Therapeutics Product and Service
-
14.4 Merck
-
14.4.1 Merck Company Details
-
14.4.2 Merck Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck Type 2 Diabetes Therapeutics Product and Service
-
14.5 Daiichi Sankyo
-
14.5.1 Daiichi Sankyo Company Details
-
14.5.2 Daiichi Sankyo Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Daiichi Sankyo Type 2 Diabetes Therapeutics Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Type 2 Diabetes Therapeutics Product and Service
-
14.7 Bristol-Myers Squibb
-
14.7.1 Bristol-Myers Squibb Company Details
-
14.7.2 Bristol-Myers Squibb Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb Type 2 Diabetes Therapeutics Product and Service
-
14.8 Sanofi
-
14.8.1 Sanofi Company Details
-
14.8.2 Sanofi Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi Type 2 Diabetes Therapeutics Product and Service
-
14.9 AstraZeneca
-
14.9.1 AstraZeneca Company Details
-
14.9.2 AstraZeneca Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 AstraZeneca Type 2 Diabetes Therapeutics Product and Service
-
14.10 Eli Lilly
-
14.10.1 Eli Lilly Company Details
-
14.10.2 Eli Lilly Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Eli Lilly Type 2 Diabetes Therapeutics Product and Service
-
14.11 Biocon
-
14.11.1 Biocon Company Details
-
14.11.2 Biocon Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Biocon Type 2 Diabetes Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Type 2 Diabetes Therapeutics
-
Figure Type 2 Diabetes Therapeutics Picture
-
Table Global Type 2 Diabetes Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Type 2 Diabetes Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Type 2 Diabetes Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Type 2 Diabetes Therapeutics Consumption by Country (2017-2022)
-
Figure United States Type 2 Diabetes Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Type 2 Diabetes Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Type 2 Diabetes Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Type 2 Diabetes Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Type 2 Diabetes Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Type 2 Diabetes Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Type 2 Diabetes Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Type 2 Diabetes Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Type 2 Diabetes Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Type 2 Diabetes Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Type 2 Diabetes Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Type 2 Diabetes Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Type 2 Diabetes Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DPP-4 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Biguanides Consumption and Growth Rate (2017-2022)
-
Figure Global Insulins Consumption and Growth Rate (2017-2022)
-
Figure Global GLP-1 Receptor Agonists Consumption and Growth Rate (2017-2022)
-
Figure Global Thiazolidenediones Consumption and Growth Rate (2017-2022)
-
Figure Global Sulfonulureas Consumption and Growth Rate (2017-2022)
-
Figure Global SGLT-2 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global A-Glucosidase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global DPP-4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biguanides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GLP-1 Receptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Thiazolidenediones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sulfonulureas Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global SGLT-2 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global A-Glucosidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Type 2 Diabetes Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Type 2 Diabetes Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Type 2 Diabetes Therapeutics Product and Service
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Type 2 Diabetes Therapeutics Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Type 2 Diabetes Therapeutics Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Type 2 Diabetes Therapeutics Product and Service
-
Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Type 2 Diabetes Therapeutics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Type 2 Diabetes Therapeutics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Type 2 Diabetes Therapeutics Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Type 2 Diabetes Therapeutics Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Type 2 Diabetes Therapeutics Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Type 2 Diabetes Therapeutics Product and Service
-
Table Biocon (Foundation Year, Company Profile and etc.)
-
Table Biocon Type 2 Diabetes Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Type 2 Diabetes Therapeutics Product and Service
-
